Deuterated drugs and biomarkers in the COVID-19 pandemic

Jansen-van Vuuren, Ross D. (avtor), Jedlovčnik, Luka (avtor), Košmrlj, Janez (avtor), Massey, Thomas E. (avtor), Derdau, Volker (avtor)

Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Initially identified in Wuhan (China) in December 2019, COVID-19 rapidly spread globally, resulting in the COVID-19 pandemic. Carriers of the SARS-CoV-2 can experience symptoms ranging from mild to severe (or no symptoms whatsoever). Although vaccination provides extra immunity toward SARS-CoV-2, there has been an urgent need to develop treatments for COVID-19 to alleviate symptoms for carriers of the disease. In seeking a potential treatment, deuterated compounds have played a critical role either as therapeutic agents or as internal MS standards for studying the pharmacological properties of new drugs by quantifying the parent compounds and metabolites. We have identified >70 examples of deuterium-labeled compounds associated with treatment of COVID-19. Of these, we found 9 repurposed drugs and >20 novel drugs studied for potential therapeutic roles along with a total of 38 compounds (drugs, biomarkers, and lipids) explored as internal mass spectrometry standards. This review details the synthetic pathways and modes of action of these compounds (if known), and a brief analysis of each study.

• Jezik: Angleški jezik
• Ključne besede: COVID-19, hydrogen isotopes, inhibitors, metabolism, pharmaceuticals
• Vrsta gradiva: Članek v reviji
• Tipologija: 1.02 - Pregledni znanstveni članek
• Organizacija: FKKT - Fakulteta za kemijo in kemijsko tehnologijo
• Status publikacije: Objavljeno
• Različica publikacije: Objavljena publikacija
• Leto izida: 2022
• Št. strani: Str. 41840-41858
• Številčenje: Vol. 7, iss. 46
• PID: 20.500.12556/RUL-144314
• UDK: 547.8:546.11
• ISSN pri članku: 2470-1343
• DOI: 10.1021/acsomega.2c04160
• COBISS.SI-ID: 131181827
• Datum objave v RUL: 14.02.2023

JANSEN-VAN VUUREN, Ross D., JEDLOVČNIK, Luka, KOŠMRLJ, Janez, MASSEY, Thomas E. in DERDAU, Volker, 2022, Deuterated drugs and biomarkers in the COVID-19 pandemic. ACS omega [na spletu]. 2022. Vol. 7, no. 46, p. 41840–41858. [Dostopano 3 maj 2025]. DOI 10.1021/acsomega.2c04160. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=144314

Gradivo je del revije

• Naslov: ACS omega
• Skrajšan naslov: ACS omega
• Založnik: American Chemical Society
• ISSN: 2470-1343
• COBISS.SI-ID: 525873945

Licence

• Licenca: CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
• Povezava: http://creativecommons.org/licenses/by/4.0/deed.sl
• Opis: To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

• Jezik: Slovenski jezik
• Ključne besede: COVID-19, izotopi vodika, inhibitorji, presnova, zdravila